Skip to main content

Legacy Advisors, LLC

Position in PFE — Pfizer Inc

CIK 1720969 PLYMOUTH MEETING, PA

Position in PFE

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$977,407
+$222,673 QoQ
Shares Held
40,590
+51.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,345
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Mar 31, 2023
CallValue
$0
CallShares
0
PutValue
$204,000
PutShares
5,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Legacy Advisors, LLC holds $21,307,408 across 9 Drug Manufacturers - General names. PFE ranks #6 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 PFE
Pfizer Inc
This page
40,590 $977,407

All Filings in PFE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $977,407 40,590
2026-03-31 $754,734 26,878
2025-12-31 $608,829 24,451
2025-09-30 $682,176 26,773
2025-03-31 $1,626,904 64,203
2024-12-31 $1,590,738 59,960
2024-09-30 $1,636,672 56,554
2024-06-30 $1,440,494 51,483
2024-03-31 $1,302,557 46,939
2023-12-31 $2,944,641 102,280
2023-09-30 $3,373,621 101,707
2023-06-30 $3,305,528 90,118
2023-03-31 $2,625,194 64,343
2023-03-31 $204,000 5,000
2022-12-31 $2,783,305 54,319
2022-09-30 $1,870,871 42,753
2022-06-30 $2,097,147 39,999
2022-03-31 $1,629,667 31,479
2021-12-31 $641,223 10,859
2021-09-30 $509,496 11,846
2021-06-30 $356,199 9,096
2021-03-31 $327,229 9,032
2020-12-31 $305,780 8,307
2020-09-30 $333,272 9,081
2020-06-30 $280,043 8,564
2020-03-31 $402,809 12,341